Drug:
Reaction: ANAEMIA
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26905845 |
EU |
58 | 2 |
Breast abscess, Body temperature increased, Liver function test abnormal, Abdominal distension, Hunger, Sleep disorder, Weight loss poor, Anxiety, Stress, Motor dysfunction, Arthropathy, Hypersensitivity, Hordeolum, Diarrhoea, Anaemia, |
||||
SERTRALINE, ABEMACICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 202 | 26905966 |
IN |
28 | 2 |
Status epilepticus, Atrial fibrillation, Pneumonia aspiration, Lactic acidosis, Respiratory acidosis, Mouth haemorrhage, Laryngeal dyskinesia, Anaemia, Acute kidney injury, Intentional overdose, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 203 | 26905969 |
CN |
||
Febrile neutropenia, Anal infection, Anaemia, Hypotension, Diarrhoea, Nausea, Fatigue, Stomatitis, Blood bilirubin increased, Alanine aminotransferase increased, Rash, Bronchitis, Gastrointestinal haemorrhage, Aspartate aminotransferase increased, Pneumonia, Sepsis, Blood creatinine increased, |
||||
RITUXIMAB, ETOPOSIDE, CYTARABINE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 204 | 26906112 |
EU |
71 | 1 |
Hypogammaglobulinaemia, Bence Jones proteinuria, Bone lesion, Anaemia, Light chain analysis increased, Proteinuria, |
||||
BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ISATUXIMAB, LENALIDOMIDE, SERTRALINE, DAPAGLIFLOZIN, |
||||
| 205 | 26906329 |
EU |
85 | |
Melaena, Anaemia, |
||||
CLOPIDOGREL, CLOPIDOGREL BISULFATE, RIVAROXABAN, DAPAGLIFLOZIN, SACUBITRIL AND VALSARTAN, EPLERENONE, EZETIMIBE, INSULIN LISPRO, LANSOPRAZOLE, NADOLOL, OXAZEPAM, INSULIN GLARGINE, NITROGLYCERIN, |
||||
| 206 | 26906369 |
CA |
80 | |
Activated partial thromboplastin time prolonged, Anaemia, Aspiration, Asthenia, Asthma, Bacterial infection, Benign prostatic hyperplasia, Blood calcium increased, Blood creatinine increased, Blood test abnormal, Breath sounds abnormal, Bronchopulmonary aspergillosis allergic, Cardiovascular disorder, Chronic obstructive pulmonary disease, Condition aggravated, Congenital hiatus hernia, Coronary artery disease, Diabetes mellitus, Drug hypersensitivity, Drug intolerance, End stage renal disease, Fatigue, Full blood count abnormal, Gastrointestinal disorder, General physical health deterioration, Gout, Headache, Hypercholesterolaemia, Hyperlipidaemia, Hyperphosphataemia, Hypertension, Hyponatraemia, Hypophosphataemia, Joint injury, Liver disorder, Lower respiratory tract infection, Lung disorder, Malignant melanoma stage 0, Micturition urgency, Multiple organ dysfunction syndrome, Musculoskeletal stiffness, Myasthenia gravis, Neuralgia, Oedema peripheral, Pain, Pleuritic pain, Pulmonary embolism, Pyrexia, Respiratory symptom, Sepsis, Sleep disorder, Sleep disorder therapy, Somnolence, Stress, Swelling, Transaminases increased, Transient ischaemic attack, Tremor, Thrombosis, Troponin increased, Ulcer, Upper respiratory tract infection, Drug ineffective, Analgesic therapy, Antacid therapy, Anticoagulant therapy, Drug therapy, Incorrect route of product administration, Intentional product misuse, Off label use, Product dose omission issue, Product use in unapproved indication, |
||||
MESALAMINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DEXLANSOPRAZOLE, LANTHANUM CARBONATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MAGNESIUM OXIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 207 | 26906380 |
CN |
66 | 1 |
Platelet count decreased, Hypothyroidism, Myocardial infarction, Pulmonary embolism, Catheter site thrombosis, Anaemia, Sinus bradycardia, Fatigue, Decreased appetite, Nausea, Vomiting, Weight increased, Blood alkaline phosphatase increased, Blood creatinine increased, Mouth haemorrhage, Glossodynia, Amylase increased, |
||||
NIVOLUMAB, CISPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 208 | 26906503 |
EU |
46 | 2 |
Pneumocystis jirovecii infection, Retroperitoneal cancer, Condition aggravated, Campylobacter bacteraemia, Immunodeficiency, Candida infection, Retroperitoneal mass, Mucosal inflammation, Respiratory tract infection, COVID-19, Escherichia urinary tract infection, Retroperitoneal lymphadenopathy, Blood immunoglobulin M decreased, Blood immunoglobulin A decreased, Anaemia, Viral infection, Fungal infection, Serum ferritin decreased, Acute sinusitis, Vascular purpura, Blood immunoglobulin G decreased, Clostridium test positive, Influenza, Lymphadenopathy, |
||||
RITUXIMAB, |
||||
| 209 | 26906512 |
JP |
29 | 2 |
Paroxysmal nocturnal haemoglobinuria, Anaemia, Fatigue, Drug ineffective, |
||||
BELIMUMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, HYDROXYCHLOROQUINE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 210 | 26906875 |
86 | 1 | |
Anaemia, |
||||
RIVAROXABAN, SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE TABLES AF, SOTALOL HYDROCHLORIDE TABLETS AF, |
||||
| 211 | 26907318 |
EU |
47 | 1 |
Thrombocytopenia, Anaemia, Renal failure, |
||||
RIBAVIRIN, RIBAVIRIN, RIBAVIRIN, PEGINTERFERON ALFA-2A, PEGINTERFERON ALFA-2A, PEGINTERFERON ALFA-2A, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ALBUMIN HUMAN, IRON, GLYBURIDE, PROPRANOLOL HYDROCHLORIDE, SPIRONOLACTONE, |
||||
| 212 | 26907319 |
US |
3 | 2 |
Parvovirus B19 infection, Respiratory failure, Acute kidney injury, Anaemia, Product prescribing issue, |
||||
PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, TACROLIMUS, TACROLIMUS, TACROLIMUS, TACROLIMUS, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 213 | 26907383 |
BR |
72 | 2 |
Neuropathy peripheral, Anaemia, Drug ineffective, Urinary incontinence, |
||||
MIRABEGRON, MIRABEGRON, MIRABEGRON, CALCIUM, |
||||
| 214 | 26907623 |
US |
50 | 1 |
Pulmonary blastomycosis, Presyncope, Arthralgia, Anaemia, |
||||
INFLIXIMAB, PREDNISONE, AZATHIOPRINE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 215 | 26907739 |
CN |
||
Insomnia, Aspartate aminotransferase increased, Alanine aminotransferase increased, Gamma-glutamyltransferase increased, Coagulopathy, Vomiting, Nausea, Decreased appetite, Hypertension, Abdominal distension, Abdominal pain, Back pain, Cough, Asthma, Weight decreased, Rash, Hypothyroidism, Blood creatinine increased, Anaemia, Blood bilirubin increased, Pneumonia, Blood albumin decreased, Constipation, Pyrexia, Lymphopenia, Neutropenia, Thrombocytopenia, Fatigue, Hypoacusis, |
||||
CAPECITABINE, ATEZOLIZUMAB, DURVALUMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CISPLATIN, OXALIPLATIN, OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 216 | 26907922 |
EU |
55 | 2 |
General physical health deterioration, Thrombosis, Anaemia, Body temperature increased, Leukopenia, Thrombocytopenia, |
||||
CARBOPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 217 | 26908102 |
EU |
71 | 1 |
Hypogammaglobulinaemia, Bence Jones proteinuria, Bone lesion, Anaemia, Light chain analysis increased, Proteinuria, |
||||
LENALIDOMIDE, BORTEZOMIB, ISATUXIMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SERTRALINE, DAPAGLIFLOZIN, |
||||
| 218 | 26908172 |
CN |
62 | 1 |
Upper gastrointestinal haemorrhage, Fall, Gastritis erosive, Chronic gastritis, Haematemesis, Abdominal distension, Anaemia, Melaena, Discoloured vomit, Gastric ulcer, Syncope, Dizziness, Faeces discoloured, Diarrhoea, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 219 | 26908224 |
US |
1 | |
Warm autoimmune haemolytic anaemia, Dyspnoea, Chromaturia, Anaemia, Loss of consciousness, Platelet count decreased, |
||||
ELTROMBOPAG, ELTROMBOPAG OLAMINE, RITUXIMAB, |
||||
| 220 | 26908241 |
86 | ||
Anaemia, |
||||
RIVAROXABAN, SOTALOL HYDROCHLORIDE, SOTALOL HYDROCHLORIDE TABLES AF, SOTALOL HYDROCHLORIDE TABLETS AF, |
||||
| 221 | 26908281 |
US |
52 | 2 |
Cytomegalovirus colitis, Anaemia, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, |
||||
| 222 | 26908508 |
US |
87 | |
Cardiac failure acute, Acute respiratory failure, Acute kidney injury, Left ventricular failure, Anaemia, |
||||
ACORAMIDIS HYDROCHLORIDE, RIVAROXABAN, RIVAROXABAN, BISOPROLOL FUMARATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUMETANIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 223 | 26908655 |
US |
69 | |
Decreased appetite, Fatigue, Nausea, Contusion, Anaemia, Asthenia, Chills, Off label use, |
||||
RUXOLITINIB, |
||||
| 224 | 26908787 |
EU |
59 | 1 |
Anal injury, Nephrolithiasis, Rectal haemorrhage, Haemorrhoids, Anaemia, Viral infection, Pyrexia, Rash, Constipation, Back pain, Upper respiratory tract infection, |
||||
LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, |
||||
| 225 | 26908885 |
CN |
63 | 2 |
Inflammatory marker increased, Joint stiffness, Pain, Anaemia, Ligament sprain, Disease recurrence, |
||||
UPADACITINIB, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, |
||||
| 226 | 26909186 |
US |
62 | 1 |
Febrile neutropenia, Anaemia, Neutropenia, Thrombocytopenia, Product use issue, |
||||
IVOSIDENIB, CYTARABINE, |
||||
| 227 | 26909191 |
US |
67 | 1 |
Malignant neoplasm progression, Anaemia, Neutropenia, Thrombocytopenia, Febrile neutropenia, Infection, Sepsis, Product use issue, |
||||
IVOSIDENIB, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 228 | 26909193 |
US |
61 | 2 |
Malignant neoplasm progression, Anaemia, Neutropenia, Febrile neutropenia, Thrombocytopenia, Sepsis, Product use issue, |
||||
IVOSIDENIB, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 229 | 26909203 |
US |
69 | 1 |
Cardiac arrest, Neutropenia, Anaemia, Thrombocytopenia, Product use issue, |
||||
IVOSIDENIB, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 230 | 26909204 |
US |
61 | 2 |
Malignant neoplasm progression, Anaemia, Neutropenia, Thrombocytopenia, Febrile neutropenia, Infection, Product use issue, |
||||
IVOSIDENIB, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 231 | 26909206 |
US |
67 | 2 |
Malignant neoplasm progression, Anaemia, Neutropenia, Thrombocytopenia, Febrile neutropenia, Sepsis, Product use issue, |
||||
IVOSIDENIB, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 232 | 26909407 |
US |
2 | |
Anaemia, Gastrointestinal haemorrhage, Restless legs syndrome, Emphysema, |
||||
DUPILUMAB, ALBUTEROL SULFATE, BENZONATATE, MAGNESIUM OXIDE, PREDNISONE, ROPINIROLE, TIOTROPIUM BROMIDE INHALATION SPRAY, LEVOTHYROXINE SODIUM, |
||||
| 233 | 26918672 |
78 | 2 | |
Anaemia, |
||||
MAVACAMTEN, |
||||
| 234 | 26918759 |
69 | 1 | |
Anaemia, Pneumonia, Decreased immune responsiveness, |
||||
ETANERCEPT, |
||||
| 235 | 26903641 |
EU |
59 | 1 |
Anal injury, Nephrolithiasis, Rectal haemorrhage, Anaemia, Haemorrhoids, Viral infection, Pyrexia, Rash, Constipation, Back pain, Upper respiratory tract infection, |
||||
LENALIDOMIDE, |
||||
| 236 | 26903677 |
US |
74 | 1 |
Gastrointestinal toxicity, Anaemia, Jugular vein thrombosis, |
||||
CARBOPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 237 | 26904107 |
US |
74 | 1 |
Gastrointestinal toxicity, Anaemia, Jugular vein thrombosis, Off label use, |
||||
CARBOPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 238 | 26902863 |
EU |
37 | |
Surgery, Hospitalisation, Crohn^s disease, Therapeutic product effect incomplete, Arthropathy, Therapeutic product effect incomplete, Drug ineffective, Therapeutic product effect incomplete, Drug ineffective, Drug ineffective, Anaemia, |
||||
UPADACITINIB, INFLIXIMAB, INFLIXIMAB, USTEKINUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, VEDOLIZUMAB, PREDNISONE, |
||||
| 239 | 26902868 |
EU |
48 | 1 |
Thrombocytopenia, Neutropenia, Anaemia, |
||||
CISPLATIN, LEVETIRACETAM, ENOXAPARIN SODIUM, ENOXAPARIN SODIUM, ENOXAPARIN SODIUM, ENOXAPARIN SODIUM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 240 | 26903471 |
US |
18 | 2 |
Anaemia, |
||||
UPADACITINIB, |
||||
| 241 | 26897588 |
US |
85 | 2 |
Medical device implantation, Blood sodium decreased, Anaemia, |
||||
EVOLOCUMAB, |
||||
| 242 | 26897596 |
CA |
47 | 2 |
Febrile neutropenia, Thrombocytopenia, Anaemia, Cystitis, |
||||
CARBOPLATIN, CARBOPLATIN, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, VALACYCLOVIR HYDROCHLORIDE, DIVALPROEX SODIUM, ERGOCALCIFEROL, DEXLANSOPRAZOLE, ESTRADIOL, CALCIUM, PROGESTERONE, CLONAZEPAM, HYDROMORPHONE HYDROCHLORIDE, |
||||
| 243 | 26897628 |
JP |
41 | 2 |
Anaemia, Tachycardia, |
||||
TREPROSTINIL, |
||||
| 244 | 26897670 |
CA |
79 | 1 |
Anaemia, Abdominal pain upper, Back pain, |
||||
ADALIMUMAB, |
||||
| 245 | 26897688 |
CA |
62 | 2 |
Acute kidney injury, Renal tubular necrosis, Transfusion, Anaemia, General physical health deterioration, Hypokalaemia, Tubulointerstitial nephritis, |
||||
CARBOPLATIN, ETOPOSIDE, DURVALUMAB, PANTOPRAZOLE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PROCHLORPERAZINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 246 | 26897734 |
28 | 2 | |
Pneumonia aspiration, Lactic acidosis, Respiratory acidosis, Acute kidney injury, Anaemia, Status epilepticus, Atrial fibrillation, Mouth haemorrhage, Laryngeal dyskinesia, Intentional overdose, Off label use, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 247 | 26897848 |
US |
2 | |
Secondary adrenocortical insufficiency, Dyspnoea, Anaemia, Gait inability, Off label use, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 248 | 26898090 |
CO |
67 | 1 |
Peripheral venous disease, Anaemia, |
||||
PANITUMUMAB, |
||||
| 249 | 26898304 |
US |
74 | 1 |
Haemothorax, Dyspnoea, Hypoxia, Pleural effusion, Superficial vein thrombosis, Anaemia, Heparin-induced thrombocytopenia, Platelet count decreased, Pulmonary embolism, Deep vein thrombosis, |
||||
HEPARIN SODIUM, HEPARIN SODIUM, |
||||
| 250 | 26898333 |
BR |
59 | 1 |
Tumour lysis syndrome, Anaemia, Infection, Fatigue, Neoplasm malignant, Hypercalcaemia, |
||||
RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, PREDNISONE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, OXALIPLATIN, RIVAROXABAN, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, |
||||
| 251 | 26898392 |
CN |
71 | |
Hypoproteinaemia, Electrolyte imbalance, Nausea, Vomiting, Hepatic function abnormal, Anaemia, |
||||
TRAMETINIB, |
||||
| 252 | 26898776 |
EU |
54 | 2 |
Anaemia, |
||||
LINEZOLID, MOXIFLOXACIN HYDROCHLORIDE, AMLODIPINE, LACOSAMIDE, LANSOPRAZOLE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, |
||||
| 253 | 26898957 |
US |
39 | 2 |
Hepatocellular injury, Transaminases increased, Fatigue, Anaemia, Nausea, |
||||
OMADACYCLINE, CLOFAZIMINE, |
||||
| 254 | 26899212 |
EU |
64 | 2 |
Leukopenia, Anaemia, Neutropenia, Off label use, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, BEVACIZUMAB, CISPLATIN, LEVOTHYROXINE SODIUM, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 255 | 26899434 |
EU |
50 | 2 |
Neutropenia, Deep vein thrombosis, Anaemia, Rash, Onychoclasis, Positron emission tomogram abnormal, Pulmonary mass, |
||||
OSIMERTINIB, CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, |
||||
| 256 | 26899536 |
EU |
||
Acute myeloid leukaemia, Infection, Bacteraemia, Pneumonia, Thrombocytopenia, Neutropenia, Haematotoxicity, Myelosuppression, Anaemia, Hepatic enzyme increased, Febrile neutropenia, Sepsis, Unevaluable event, Drug ineffective, |
||||
AZACITIDINE, AZACITIDINE FOR, VENETOCLAX, |
||||
| 257 | 26899570 |
EU |
71 | 1 |
Hypogammaglobulinaemia, Bence Jones proteinuria, Bone lesion, Anaemia, Light chain analysis increased, Proteinuria, |
||||
BORTEZOMIB, LENALIDOMIDE, ISATUXIMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SERTRALINE, DAPAGLIFLOZIN, |
||||
| 258 | 26899607 |
EU |
||
Anaemia, Neutropenia, Neurotoxicity, |
||||
ATEZOLIZUMAB, CARBOPLATIN, ETOPOSIDE, |
||||
| 259 | 26899619 |
US |
67 | 1 |
Anaemia, |
||||
LENALIDOMIDE, |
||||
| 260 | 26899651 |
TR |
50 | 2 |
Anaemia, Myelosuppression, Immunoglobulins decreased, Blood disorder, |
||||
OCRELIZUMAB, |
||||
| 261 | 26899738 |
GB |
87 | 1 |
Anaemia, |
||||
DUPILUMAB, |
||||
| 262 | 26899872 |
BR |
2 | |
Volvulus, Coma, Immunodeficiency, Immunodeficiency, Metastases to liver, Neutropenia, Metastases to pelvis, Liver injury, Bone lesion, Weight decreased, Breast cancer, Hypoaesthesia, Metastasis, Metastases to spine, Haemorrhage, Cataract, Dark circles under eyes, Wound, Carbohydrate antigen 15-3 increased, Dry skin, Nail disorder, Red blood cell count decreased, White blood cell count decreased, Drug hypersensitivity, Rash papular, Nausea, Nausea, Eye swelling, Vulvovaginal burning sensation, Illness, Alopecia, Oral discomfort, Eyelid disorder, Haematoma, Muscular weakness, Blood disorder, Skin disorder, Tumour marker decreased, Vitamin D decreased, Malaise, Blood test abnormal, Back pain, Musculoskeletal chest pain, Cardiac disorder, Pallor, Ill-defined disorder, Skin discolouration, Administration site pain, Blood creatinine abnormal, Erythema, Asthenia, Dizziness, Anxiety, Abdominal pain, Anaemia, Fatigue, Red blood cell count decreased, Pruritus, Hypotension, White blood cell count decreased, Abdominal pain upper, Somnolence, Skin discolouration, Visual impairment, Road traffic accident, Bone erosion, Labyrinthitis, Skeletal injury, Pain, Bone pain, Blood creatinine increased, Aspartate aminotransferase increased, Alanine aminotransferase increased, Somnolence, Somnolence, Somnolence, Blood urea increased, Chest pain, Platelet count decreased, Product dose omission issue, |
||||
FULVESTRANT, CAPECITABINE, CAPECITABINE, CAPECITABINE, CAPECITABINE, CAPECITABINE, ALPRAZOLAM, ALPRAZOLAM, LOSARTAN, AMLODIPINE, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, ANASTROZOLE, ONDANSETRON HYDROCHLORIDE, |
||||
| 263 | 26900054 |
US |
66 | 1 |
Dyspnoea, Anaemia, Renal disorder, |
||||
DUPILUMAB, |
||||
| 264 | 26901194 |
IN |
28 | 2 |
Atrial fibrillation, Pneumonia aspiration, Lactic acidosis, Respiratory acidosis, Laryngeal dyskinesia, Acute kidney injury, Mouth haemorrhage, Status epilepticus, Anaemia, Intentional overdose, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 265 | 26901227 |
JP |
65 | 2 |
Malignant neoplasm progression, Anaemia, Enterocolitis, Diarrhoea, |
||||
PEMBROLIZUMAB, ENFORTUMAB VEDOTIN, |
||||
| 266 | 26901542 |
US |
81 | 2 |
Deep vein thrombosis, Anaemia, Gastrooesophageal reflux disease, Hypertension, Presyncope, Acquired cardiac septal defect, |
||||
| 267 | 26901737 |
EU |
55 | 2 |
Leukopenia, Thrombocytopenia, Body temperature increased, Anaemia, Thrombosis, General physical health deterioration, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, |
||||
| 268 | 26901779 |
EU |
81 | 1 |
Hyperpyrexia, Anaemia, Asthenia, Dyspepsia, |
||||
IMATINIB, |
||||
| 269 | 26901861 |
EU |
1 | |
Blood loss anaemia, Splenomegaly, Anaemia, Pain in extremity, Mean cell haemoglobin concentration abnormal, Platelet count abnormal, Therapy partial responder, |
||||
VALSARTAN, VALSARTAN ORAL, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, AMLODIPINE, BISOPROLOL FUMARATE, DOXAZOSIN, DOXAZOSIN MESYLATE, APIXABAN, PROPAFENONE, TORSEMIDE, EPLERENONE, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, FENOFIBRATE, ALPRAZOLAM, DABIGATRAN ETEXILATE, |
||||
| 270 | 26901983 |
US |
82 | 1 |
Anaemia, Febrile neutropenia, Infection, Thrombocytopenia, Sepsis, Malignant neoplasm progression, Product use issue, |
||||
IVOSIDENIB, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 271 | 26902068 |
EU |
16 | 2 |
Cachexia, Amenorrhoea, Hypoalbuminaemia, Autoimmune hepatitis, Pneumonia streptococcal, Crohn^s disease, Anaemia, Oedema peripheral, COVID-19, Influenza, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 272 | 26902090 |
CN |
62 | 1 |
Malignant neoplasm progression, Acute respiratory failure, Blood albumin abnormal, Bronchitis, Anaemia, Malnutrition, |
||||
NIVOLUMAB, NIVOLUMAB, NIVOLUMAB, NIVOLUMAB, NIVOLUMAB, NIVOLUMAB, NIVOLUMAB, NIVOLUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, CISPLATIN, CISPLATIN, CISPLATIN, |
||||
| 273 | 26902375 |
US |
20 | 1 |
Ocular icterus, Pyrexia, Viral infection, Anaemia, |
||||
MITAPIVAT, |
||||
| 274 | 26902414 |
CN |
71 | 2 |
Nausea, Vomiting, Blood potassium decreased, Blood sodium decreased, Blood calcium decreased, Hepatic function abnormal, Anaemia, Hypoproteinaemia, Pyrexia, Abdominal pain, Abdominal distension, Dizziness, Chills, Decreased appetite, Asthenia, Marasmus, |
||||
TRAMETINIB, DABRAFENIB, |
||||
| 275 | 26907827 |
36 | 2 | |
Anaemia, Haemoglobin decreased, |
||||
DARATUMUMAB, |
||||
| 276 | 26891963 |
CA |
2 | |
Dyspnoea, Anaemia, Intellectual disability, Dyspnoea exertional, Product ineffective, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 277 | 26892327 |
EU |
12 | 2 |
Oral mucosal eruption, Hypokalaemia, Stevens-Johnson syndrome, Anaemia, Vomiting, Hypoalbuminaemia, Hypocalcaemia, Osteolysis, Oedema, Erythema multiforme, Alanine aminotransferase increased, Oral candidiasis, Constipation, Nausea, |
||||
POVIDONE, MESNA, MESNA INJECTION, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, CYTARABINE, METHOTREXATE SODIUM, PROPOFOL, ROCURONIUM BROMIDE, ALBENDAZOLE, ALLOPURINOL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, HEPARIN SODIUM, BUPRENORPHINE HYDROCHLORIDE, COLISTIMETHATE SODIUM, IFOSFAMIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PROMETHAZINE HYDROCHLORIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, MIDAZOLAM HYDROCHLORIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MESNA, MESNA INJECTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYTARABINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, MIDAZOLAM HYDROCHLORIDE, ALBUMIN HUMAN, METHOTREXATE, METHOTREXATE SODIUM, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, BUPRENORPHINE HYDROCHLORIDE, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 278 | 26892418 |
JP |
54 | 2 |
Encephalitis autoimmune, Blood pressure decreased, Platelet count decreased, Anaemia, Pyrexia, Disseminated intravascular coagulation, |
||||
PEMBROLIZUMAB, LENVATINIB, |
||||
| 279 | 26892502 |
US |
25 | 2 |
Anaemia, Fatigue, |
||||
OMAVELOXOLONE, |
||||
| 280 | 26893032 |
EU |
61 | |
Anaemia, Suspected off label use, Drug effective for unapproved indication, |
||||
BEVACIZUMAB, |
||||
| 281 | 26893229 |
EU |
2 | |
Anaemia, Neutropenia, Gastrointestinal toxicity, |
||||
BEVACIZUMAB, |
||||
| 282 | 26893262 |
EU |
77 | 2 |
Anaemia, Aphthous ulcer, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, OXALIPLATIN, |
||||
| 283 | 26893351 |
JP |
72 | 2 |
Anaphylactic reaction, Anaemia, Neutrophil count decreased, Platelet count decreased, Rash, Alopecia, |
||||
DURVALUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, |
||||
| 284 | 26893378 |
KR |
66 | |
Mechanical ileus, Febrile neutropenia, Polyneuropathy, Leukopenia, Anaemia, Bronchitis, |
||||
BEVACIZUMAB-ADCD, BEVACIZUMAB-ADCD, BEVACIZUMAB-ADCD, BEVACIZUMAB-ADCD, BEVACIZUMAB-ADCD, BEVACIZUMAB-ADCD, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, |
||||
| 285 | 26893391 |
JP |
||
Neutropenia, Thrombocytopenia, Neuropathy peripheral, Anaemia, Rash, Paronychia, Diarrhoea, Stomatitis, Taste disorder, |
||||
OSIMERTINIB, |
||||
| 286 | 26893761 |
US |
74 | 2 |
Anaemia, Drug ineffective, Nausea, Diarrhoea, Vomiting, |
||||
IMATINIB, |
||||
| 287 | 26893823 |
AR |
31 | 2 |
Anaemia, Pneumonia, |
||||
CLADRIBINE, |
||||
| 288 | 26894097 |
EU |
25 | 2 |
Anaemia, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, BRENTUXIMAB VEDOTIN, ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DACARBAZINE, |
||||
| 289 | 26894353 |
US |
79 | 2 |
Meningitis bacterial, Off label use, Metabolic encephalopathy, Gait disturbance, Major depression, Muscular weakness, Gait disturbance, Vascular dementia, Anaemia, Fall, Hyperlipidaemia, Hypertensive heart disease, Myelodysplastic syndrome, Neutropenia, Pancytopenia, Sepsis, |
||||
VENETOCLAX, VENETOCLAX, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 290 | 26894432 |
BR |
48 | 2 |
Blood cholesterol increased, Blood pressure increased, Nodule, Vaginal haemorrhage, Neoplasm recurrence, Bone neoplasm, Tumour inflammation, Neutropenia, Febrile neutropenia, Breast cancer metastatic, Malignant neoplasm progression, Hyperhidrosis, Madarosis, Pain, Pain, Pain, Menstrual disorder, Hair growth abnormal, Insomnia, Decreased immune responsiveness, Fatigue, Asthenia, Alopecia, Swelling, Weight increased, Hormone level abnormal, Feeling abnormal, Polymerase chain reaction positive, Iron deficiency, Sensory loss, Menstrual disorder, Menstrual disorder, Breast swelling, Nervousness, Crying, Weight decreased, Feeling hot, Skin burning sensation, Erythema, Erythema, Breast swelling, Gene mutation, Breast pain, Cardiac disorder, Blood triglycerides increased, Anaemia, Breast swelling, Application site injury, Application site oedema, Application site discolouration, Infection, Anal incontinence, Malaise, Feeling cold, Diarrhoea, Platelet count decreased, Abdominal pain upper, Abdominal pain, Abdominal pain, Pyrexia, Therapy non-responder, Headache, Headache, Vision blurred, Vision blurred, Vision blurred, Abdominal pain, Faeces soft, Blood glucose increased, Tinnitus, Mood altered, Ear pain, Dry mouth, Skin exfoliation, Pruritus, Irritability, |
||||
CIPROFLOXACIN HYDROCHLORIDE, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, GOSERELIN, DENOSUMAB, ALPELISIB, FULVESTRANT, SACCHAROMYCES CEREVISIAE, METRONIDAZOLE, |
||||
| 291 | 26894505 |
EU |
57 | 2 |
Anaemia, Herpes zoster, Immunoglobulins decreased, Reticulocytopenia, Parvovirus B19 infection, Aplasia pure red cell, |
||||
LENALIDOMIDE, LENALIDOMIDE, TISAGENLECLEUCEL, RITUXIMAB, MOSUNETUZUMAB, MOSUNETUZUMAB, PREGABALIN, |
||||
| 292 | 26895507 |
GB |
2 | |
Anaemia, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 293 | 26895937 |
US |
74 | 1 |
Anaemia, Off label use, |
||||
PACRITINIB, |
||||
| 294 | 26895962 |
EU |
36 | 2 |
Cystitis interstitial, Feeling drunk, Discomfort, Feeling hot, Abdominal discomfort, Anxiety, Chills, Decreased immune responsiveness, Joint injury, Feeling abnormal, Feeding disorder, Blood calcium abnormal, Pain in extremity, Bone pain, Ear, nose and throat disorder, Oropharyngeal pain, Myalgia, Radiation inflammation, Pharyngeal swelling, Bacterial test positive, Insomnia, Constipation, Lymphoedema, Muscle contracture, Dizziness, Fatigue, Headache, Diarrhoea, Anaemia, Vomiting, Nausea, Decreased appetite, Asthenia, |
||||
ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, EXEMESTANE, EXEMESTANE, EXEMESTANE, EXEMESTANE, GOSERELIN, GOSERELIN, GOSERELIN, GOSERELIN, |
||||
| 295 | 26896004 |
US |
23 | 1 |
Anaemia, |
||||
ADALIMUMAB, ADALIMUMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, USTEKINUMAB, UPADACITINIB, |
||||
| 296 | 26896257 |
ML |
57 | 1 |
Anaemia, Decreased appetite, Loss of consciousness, Weight decreased, Melaena, |
||||
| 297 | 26896266 |
US |
2 | |
Epigastric discomfort, Hot flush, Pain, Malaise, Arthralgia, Muscle spasms, Pain in extremity, Abdominal distension, Dizziness, Abdominal pain, Anaemia, Diarrhoea, Splenomegaly, White blood cell count increased, Fatigue, Weight decreased, Decreased appetite, Night sweats, Product dose omission issue, Contusion, Drug resistance, |
||||
HYDROXYUREA, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, FEDRATINIB HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZELAIC ACID, 12%AZELAIC ACID, 14%AZELAIC ACID, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FAMOTIDINE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, NITROGLYCERIN, ALLOPURINOL, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, |
||||
| 298 | 26896383 |
US |
2 | |
Anaemia, Renal impairment, Palmar-plantar erythrodysaesthesia syndrome, Rash, Mucosal inflammation, |
||||
CAPIVASERTIB, |
||||
| 299 | 26896533 |
EU |
30 | |
Tumour haemorrhage, General physical health deterioration, Alopecia, Asthenia, Anaemia, Diarrhoea, |
||||
SACITUZUMAB GOVITECAN, |
||||
| 300 | 26896812 |
71 | 2 | |
Electrolyte imbalance, Anaemia, |
||||
LENALIDOMIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
